Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global tablet coatings market attained a value of USD 875.85 Million in 2025 and is projected to expand at a CAGR of 5.50% through 2035. The market is further expected to achieve USD 1496.08 Million by 2035. Rapid growth in complex oral pharmaceuticals is leading to an increased need for coating solutions with higher stability, controlled release ability, taste masking, and improved efficiency in high-speed processing.
Development of generics and CDMOs is leading to the demand for standardized coating solutions that can speed up the process of formulation and technology transfer, thereby boosting the tablet coatings market growth. At the same time, increasing demands on product stability are resulting in a trend toward moisture barrier and functional coatings. This is prompting suppliers to come up with coating solutions tailored to specific applications and provide technical support to help pharmaceutical companies avoid batch failures and get consistently good results.
The tablet coatings industry is further characterized by innovative technologies in formulation that enhance the efficiency of production processes while allowing for increasingly sophisticated oral solid-dose formulations. An important milestone achieved by Colorcon is the June 2025 expansion of their portfolio of Opadry with the launch of ready-to-use film-coating solutions that will enable simplified production process and ensure uniformity. This solution is especially relevant considering the leading position of oral solid dosage forms. Tablets and capsules make up about 70% of all pharmaceutical products produced in the world, thus creating the high demand for the solution that will allow to provide uniform appearance, moisture protection and functional properties.
The other area where major suppliers in the tablet coatings market invest efforts is higher value-added applications such as modified release, enteric, moisture barrier and taste masking. Companies such as BASF and Evonik are aiming at advanced polymers and formulation capabilities that will allow pharmaceutical manufacturers to create unique tablets and reduce variability in production process. For example, in February 2025, Roquette launched an innovative coating platform, improving pharmaceutical tablet appearance, functionality, stability, and manufacturing efficiency.
Compound Annual Growth Rate
5.5%
Value in USD Million
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Hovione increased its Loures site’s capacity by 25% through commercial tablet compression and film coating capabilities for flexibility and redundancy. Other businesses can increase their capability for tablet coating and manufacture in order to meet the increasing demand for flexible oral solid dosage production.
BITS Pilani created a pharmaceutical polymer hydrogel used for 3D printed tissue scaffolds and custom chewable tablets, which opens up new opportunities for drug delivery. Companies can create functional coating solutions for custom drug delivery and controlled release applications, thereby boosting growth in the tablet coatings market.
Ashland commenced setting up its first South Asia aquarius tablet coatings production plant in the vicinity of Mumbai, India. This will help provide better supplies, technical support, and pharmaceutical customer responsiveness for the region. Other competitors may set up localized facilities that offer better supplies and responsiveness in the fast-growing regions.
Colorcon introduced the OneLock system that provides desiccant, child resistant, tamper proof, and moisture protective closure. This will assist pharmaceutical companies in providing better packaging solutions for their sensitive tablets. Companies in the tablet coatings market can therefore develop moisture-proof and coating compatible packaging solutions.
The expansion in generic drugs is resulting in the demand for efficient and reproducible coating processes for tablets, ensuring quality attributes including appearance, stability, and dissolution. 9 out of 10 prescriptions dispensed in the United States are generics according to FDA. Hence, the tablet coatings market observes significant demand to produce oral solid dosage forms. Moreover, FDA finalized guidance for M13A for the bioequivalence study for immediate release tablets and capsules. These regulations will ensure the provision of characterized coating processes. For instance, companies like Colorcon are developing complete film coating systems. Demonstrating similar trends, in August 2025, Extrovis and Dr. Reddy’s launched FDA-approved generic Fluorouracil Cream 0.5%, expanding affordable treatment access for actinic keratoses.
Innovations in enteric coating and targeted drug delivery are compelling enteric coating suppliers to innovate beyond traditional application areas. Evonik's EUDRATEC Fasteric offers dual protection through gastric barriers with fast drug release. This can be an advantage for APIs that have a narrow window for absorption. It enables coating suppliers to develop enteric coatings which can offer higher bioavailability through use of standard pharmaceutical equipment. The FDA's FY 2025 GDUFA science program focuses on R&D across complex dosage forms and oral formulations. Moreover, there is an opportunity for formulators who specialize in polymers offering expertise in formulation, dissolution and functional coatings for generic drugs. Aligning with this trend in the tablet coatings market, in April 2026, BIOGRUND and Seprify launched mineral-free, cellulose-based tablet coatings, providing clean-label alternatives with whitening performance and improved processing stability.
Increased regulatory scrutiny in relation to the content of excipients is driving the development of alternative formulations of the coating of tablets. Companies like Colorcon are developing formulations which do not contain titanium dioxide that is aimed at offering moisture protection to pharmaceutical tablets. The EU agency's guidance in relation to coprocessed excipient is becoming legally binding and sets up the expectations in relation to risk-based quality and dossier requirements for solid oral dosage forms. This situation creates a tablet coatings market opportunity for suppliers who have documentation and characterization of materials. For example, in September 2023, Colorcon launched a titanium dioxide-free moisture-protection coating, enhancing pharmaceutical tablet stability while supporting cleaner, regulatory-compliant formulations.
Coating systems requiring less preparation, handling, and downtime by operators are becoming important priorities for manufacturers in the tablet coatings market. Evonik's EUDRAGIT IR ReadyMix White coating system is a fully formulated powder premix that can be processed in about half the time required by some HPMC- or PVA-based ready-to-use coating systems. The Opadry Complete Film Coating System from Colorcon secured the CPHI China 2025 Market Impact Award in June 2025, indicating commercial interest in simpler coating systems. Minor Changes to Certain Solid Oral OTC Dosage Forms by the FDA includes manufacturing changes in its draft guidance and indicates the need for coating systems whose change can be justified and transferred.
Growing complexities of formulations are leading to the requirement of companies in the tablet coatings market providing development assistance. In its 2026 guidance, the EMA recognized the following risks associated with the use of co-processed excipients in solid oral dosage forms including complexity of composition, quality control, formulation development, and stability. As a result of that, coating companies are coming up with multifunctional and technically well-documented coatings. In the list of FDA's planned product-specific guidance published in August 2026, many oral products find mention, indicating continuing product development pipelines and generic competition.
The Expert Market Research's report titled “Tablet Coatings Market Report and Forecast 2026-2035” offers a detailed analysis of the market based on the following segments:
Market Breakup by End Use
Key Insight: Based on their end-use applications, the pharmaceutical industry drives tablet coatings market growth owing to its need for stability, identity, taste-masking, and effective drug delivery. Nutraceuticals observe a higher growth rate due to their manufacturers’ need to improve sensory attributes, moisture resistance, and value addition to more complex combinations of ingredients. The pharmaceutical industry demands coating systems that are scientifically validated and scalable, while the nutraceutical industry needs coatings with special colors and barrier functionalities.
Market Breakup by Region
Key Insight: North America accelerates the tablet coatings market revenue growth through high-tech manufacturing in the pharmaceutical industry, stringent quality requirements, and need for special functional coatings. Europe takes advantage of its strengths in formulation and regulatory interest in environmentally friendly excipient systems. The Asia Pacific region is growing rapidly owing to generics, contract manufacturing, and increasing nutraceuticals capabilities. Latin America is supported by regional growth in the pharmaceutical industry and needs for affordable and stable oral dose formulations. Middle East and Africa are gaining momentum through local manufacturing and better medicine access.
The pharmaceuticals end use category registers the largest share of the market due to advanced drug formulation needs
The pharmaceuticals end-use category accounts for the major share of the tablet coatings market value owing to the fact that coating technology is connected to identification of the products, stability, swallowability, masking and modified drug release. Drug makers are using multi-functional film coating technologies in order to protect moisture sensitive active pharmaceutical ingredients and differentiating tablets via colors and finishes. There is potential in the high-volume generics in which the use of ready-to-use systems can aid in easy batching of batches and facilitate consistent process. In September 2025, O’Hara installed an R&D tablet coating machine at Bombay College of Pharmacy, advancing pharmaceutical research, training, and coating innovation.
The nutraceuticals end-use segment records notable growth owing to the efforts of the supplement manufacturers in creating products which offer better appearances and taste masking and protection of sensitive ingredients. Companies in the tablet coatings market are catering to the requirements of difficult formulations such as botanical extracts, minerals, probiotics, and others via customized solutions. In August 2024, Sigachi launched PureCoat and UltraMod, advanced coating solutions enhancing drug stability, delivery, absorption, patient adherence, and pharmaceutical formulation effectiveness.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America clocks in the largest share of the market due to advanced pharmaceutical manufacturing
North America is the leading regional tablet coatings market due to its well-established pharmaceutical industry which requires high consistency coating for its regulated, specialized and value-added oral solid dosage products. Suppliers are focusing on the functional coating market, which can provide moisture protection, delayed release, and increased swallowing ability. Suppliers can benefit from the demand for excipients with technical support, which can assist in managing changes in formulations.
Asia Pacific represents the fastest-growing regional tablet coatings market, as the expansion of manufacturing capacity for generics, contract manufacturing, and export-based oral solid dosage products by pharmaceutical manufacturers continues. Suppliers are focusing on scalable solutions that can make technology transfer easier for different manufacturing plants. The nutraceutical industry in the region is driving the demand for visually distinguished and flavor masking coating. There are significant opportunities for efficient premix, multifunctional polymers, and application support to supply large pharmaceutical plants. In February 2026, Piramal Pharma Solutions introduced tablet-in-capsule capabilities, enabling complex oral formulations, differentiated release profiles, and enhanced drug delivery.
Competition in the market is shifting from simple coloring to performance characteristics of the formulations. Major tablet coatings market players are developing multi-purpose formulations which offer moisture protection, opacity, masking tastes, swallowability and controlled release through a smaller number of processing steps. The emergence of ready-to-use premixes provides a chance to save on dispersion time and technology transfers especially among generics and CDMOs.
Another area that the major tablet coating companies are focusing on is regulatory innovation which includes titanium dioxide-free coatings and well-characterized coatings that can help clients cope with shifting excipients. The other areas where opportunities continue to exist include enteric coatings, fast disintegration, biologically active ingredients, and high-value nutraceuticals. Companies that can blend polymer science with processes will be able to form long-term development partnerships instead of competing on coating materials prices.
Colorcon Inc. is a company founded in 1961, based in Harleysville, Pennsylvania, United States. It supplies its customer base using film coating systems, controlled release products, and formulations. This firm adopts a strategy that incorporates ready-to-use coatings and multifunctional coatings to help process efficiently and meet changing requirements like moisture protection and the development of products without titanium dioxide.
BASF SE is a firm founded in 1865, based in Ludwigshafen, Germany. It offers pharmaceutical excipients and polymers used in film coating and oral dosage formulations. This firm addresses its customers with technically characterized ingredients, formulation knowledge, and regulatory assistance.
Kerry Inc., founded in 1983 and based in Ireland, is a provider of flavoring, sensory, and functional ingredient solutions for tablet and nutraceutical manufacturers. The solution offered by Kerry deals with consumer acceptance of nutritional products, especially when there is a need for better masking, palatability, differentiation, and appeal owing to the unpalatable tastes and complicated formulation.
Ideal Cures Pvt. Ltd., founded in 1988 and based in Mumbai, India, specializes in pharmaceutical coating systems, excipients, and formulation technologies. Ideal Cures Pvt. Ltd. offers manufacturers customized film coatings and enteric solutions as well as process solutions for various dosage forms.
Other key players in the market include Evonik Industries AG, and Sensient Technologies, among others.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Unlock the latest insights with our tablet coatings market trends 2026 report. Discover regional growth patterns, consumer preferences, and key industry players. Stay ahead of competition with trusted data and expert analysis. Download your free sample report today and drive informed decisions in the market.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
In 2025, the market reached an approximate value of USD 875.85 Million.
The market is projected to grow at a CAGR of 5.50% between 2026 and 2035.
The market is estimated to reach a value of about USD 1496.08 Million by 2035.
Key strategies driving the market include developing functional and titanium dioxide-free coatings, expanding regional manufacturing capacity, investing in advanced coating technologies, and strengthening pharmaceutical partnerships.
The key market trends include the increasing interest in customisable blends in the pharmaceuticals sector, the growing demand for pigmented film coatings, and the expansion by private firms and governments.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market.
The significant end uses of tablet coatings in the market are pharmaceuticals and nutraceuticals.
The key players in the market include Colorcon Inc., BASF SE, Kerry Inc., Ideal Cures Pvt. Ltd., Evonik Industries AG, and Sensient Technologies, among others.
Key challenges include stringent regulatory requirements, raw material price volatility, formulation complexity, and maintaining consistent coating quality across large-scale production.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 2,499
USD 2,249
tax inclusive*
Single User License
One User
USD 3,999
USD 3,599
tax inclusive*
Five User License
Five User
USD 4,999
USD 4,249
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.